A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT04632108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04632108
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2025-10-31
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.